Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Drugs Limited has informed BSE that the trading window for its securities will be closed starting 1st October 2025. The closure will remain in effect until 48 hours after the company announces its unaudited financial results for the quarter ending 30th September 2025 (Q2 FY26). During this period, all directors, designated employees, insiders, and their immediate relatives are prohibited from buying or selling the company's shares. The board meeting date to approve the Q2 results will be communicated separately.
This is a routine compliance announcement ahead of quarterly results and has no direct impact on share price. However, it signals that Q2 FY26 financial results are imminent, which investors should watch for as the next potential catalyst.